These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31896530)

  • 1. Endogenous cardiotonic steroids and cardiovascular disease, where to next?
    Pavlovic D
    Cell Calcium; 2020 Mar; 86():102156. PubMed ID: 31896530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney disease.
    Pavlovic D
    Nephron Clin Pract; 2014; 128(1-2):11-21. PubMed ID: 25341357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
    Schoner W; Scheiner-Bobis G
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.
    Bagrov AY; Shapiro JI; Fedorova OV
    Pharmacol Rev; 2009 Mar; 61(1):9-38. PubMed ID: 19325075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous cardiotonic steroids in pathogenesis of cardiovascular and renal complications of arterial hypertension.
    Paczula A; Więcek A; Piecha G
    Postepy Hig Med Dosw (Online); 2016 Mar; 70():243-50. PubMed ID: 27117099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous cardiotonic steroids in sodium homeostasis.
    Schoner W; Scheiner-Bobis G
    Nephrol Dial Transplant; 2008 Sep; 23(9):2723-9. PubMed ID: 18556748
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1
    Marck PV; Pessoa MT; Xu Y; Kutz LC; Collins DM; Yan Y; King C; Wang X; Duan Q; Cai L; Xie JX; Lingrel JB; Xie Z; Tian J; Pierre SV
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous digitalis: pathophysiologic roles and therapeutic applications.
    Bagrov AY; Shapiro JI
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):378-92. PubMed ID: 18542120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of cardiotonic steroids to Na
    Kanai R; Cornelius F; Ogawa H; Motoyama K; Vilsen B; Toyoshima C
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33318128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between cardiotonic steroids and Na,K-ATPase. Effects of pH and ouabain-induced changes in enzyme conformation.
    Cornelius F; Mahmmoud YA
    Biochemistry; 2009 Oct; 48(42):10056-65. PubMed ID: 19778013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
    Schoner W; Scheiner-Bobis G
    Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
    Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
    Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ouabain, endogenous ouabain and ouabain-like factors: The Na
    Blaustein MP; Hamlyn JM
    Cell Calcium; 2020 Mar; 86():102159. PubMed ID: 31986323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotonic steroids as potential Na
    Patel CN; Kumar SP; Modi KM; Soni MN; Modi NR; Pandya HA
    J Recept Signal Transduct Res; 2019 Jun; 39(3):226-234. PubMed ID: 31509043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensational site: the sodium pump ouabain-binding site and its ligands.
    Blaustein MP; Hamlyn JM
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1120-C1177. PubMed ID: 38223926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whither digitalis? What we can still learn from cardiotonic steroids about heart failure and hypertension.
    Blaustein MP; Gottlieb SS; Hamlyn JM; Leenen FHH
    Am J Physiol Heart Circ Physiol; 2022 Dec; 323(6):H1281-H1295. PubMed ID: 36367691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased Effect of Cardiotonic Steroids on Na/K-ATPase-Mediated Signal Transduction.
    Xu Y; Marck P; Huang M; Xie JX; Wang T; Shapiro JI; Cai L; Feng F; Xie Z
    Mol Pharmacol; 2021 Mar; 99(3):217-225. PubMed ID: 33495275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotonic steroids differentially affect intracellular Na+ and [Na+]i/[K+]i-independent signaling in C7-MDCK cells.
    Akimova OA; Bagrov AY; Lopina OD; Kamernitsky AV; Tremblay J; Hamet P; Orlov SN
    J Biol Chem; 2005 Jan; 280(1):832-9. PubMed ID: 15494417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological and clinical importance of sodium potassium ATPase in cardiovascular diseases.
    Yan Y; Shapiro JI
    Curr Opin Pharmacol; 2016 Apr; 27():43-9. PubMed ID: 26891193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.